Fig. 3: EORTC QLQ-C30 global health domain given for 4 timepoints: before therapy (after randomization), halfway therapy, at the end of therapy and at six months follow-up. | Nature Communications

Fig. 3: EORTC QLQ-C30 global health domain given for 4 timepoints: before therapy (after randomization), halfway therapy, at the end of therapy and at six months follow-up.

From: Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial

Fig. 3

Error bars indicate the 95% CI of the mean. Abbreviations: EORTC: European Organization for Research and Treatment of Cancer, FMD: fasting mimicking diet. CI: confidence interval. FMD N = 57 and regular diet N = 54. Armitage’s trend test was used. Source data are provided as a Source Data file.

Back to article page